ADC Therapeutics
ADCT
ADCT
49 hedge funds and large institutions have $501M invested in ADC Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 55 → 49 (-6)
27% less capital invested
Capital invested by funds: $683M → $501M (-$181M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
49
Holding in Top 10
3
Calls
$527K
Puts
$190K
Top Buyers
| 1 | +$5.88M | |
| 2 | +$3.23M | |
| 3 | +$2.98M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.19M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$952K |
Top Sellers
| 1 | -$5.71M | |
| 2 | -$4.9M | |
| 3 | -$1.37M | |
| 4 |
Millennium Management
New York
|
-$815K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$522K |